Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

Prostate

This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with enzalutamide.
Prostate
III
Moses, Kelvin
NCT03395197
VICCURO17115

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: